Genetic and Environmental Risks for IBD

Similar documents
What is IBD and Why Me?

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

Understanding clinical aspects of Crohn s disease and ulcerative colitis: Implications for the basic scientist

Environmental factors affecting IBD Have we made progress? Peter Laszlo Lakatos 1st Department of Medicine Semmelweis University Budapest Hungary

Genetics of Pediatric Inflammatory Bowel Disease

PEDIATRIC INFLAMMATORY BOWEL DISEASE

Material and Information Resources for Inflammatory And Digestive Diseases. What is the MICROBIOME and what does it have to do with IBD?

Causes of IBD: The Role of Genetics and Microbes and the Epidemiology of IBD

Running head: CHRON'S DISEASE GENE-ENVIRONMENTAL INTERACTION 1

Is there an anti-inflammatory diet in IBD?

Research in IBD at University of Colorado Denver

Factsheet - Risk factors for inflammatory bowel disease (IBD)

Clinical Trials in IBD. Bruce Yacyshyn MD Professor of Medicine Division of Digestive Diseases

Kids Like to Break the Rules: Gastrointestinal Pathology in Children

Update in Pediatric IBD: 2018

Immunological Tolerance

10/11/2010. Jonathan Braun, MD, PhD David Geffen School of Medicine at UCLA CCFA National Scientific Advisory Committee

Epidemiology of Inflammatory Bowel Disease

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Where did Inflammatory Bowel Disease come from? What the history tells us. about emerging therapies.

Signal Transduction in Inflammatory Bowel Disease

Exploration of the microbiota in inflammatory diseases. Matthew Stoll MD Research Computing Day September 13, 2012

Intestinal Microbiota in Health and Disease

Epidemiology of Inflammatory Bowel Disease and Overview of Pathogenesis

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD

Issues at Hand. Inflammatory Bowel Disease Paradigm. Diet changes the fecal microbiome. Experience with diet in IBD

Ali Keshavarzian MD Rush University Medical Center, Chicago, IL

Date of preparation: 06/ IBD/

Inflammatory Bowel Disease Ischemic bowel disease

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Faecalibacterium prausnitzii

Murine Models of. Inflammatory Bowel Disease. Outline. Laura P. Hale, M.D. Ph.D. Professor of Pathology Duke University Medical Center

Inflammatory Bowel Disease and Surgery: What You Should Know

Microbiome GI Disorders

Gut Microbiome Essentials

Speaker Introduction

Gut Lung Axis Implication of the Gut Microbiota beyond its niche

Etiology, Assessment and Treatment

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

MICROBIOM AND OBESITY HEINZ GYAKY 2018 BUDAPEST

Crohn s Disease. Naturopathic Treatment Options

Chapter 5: Common Digestive Problems from The Kansas State University Human Nutrition (HN 400) Flexbook by Brian Lindshield is in the public domain

Materials EXCLUSION CRITERIA INCLUSION CRITERIA

East west gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

Zach Johnson---Masters Champion

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

UNDERSTANDING CROHN S DISEASE

Inflammatory Bowel Disease A model for translational medicine. D P Jewell Professor Emeritus of Gastroenterology University of Oxford

fever a persistent unexplained change in bowel habit in somebody over 50 years of age a family history of bowel or ovarian cancer.

Dietary Options for Inflammatory Bowel Disease

Exosomes as a. Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE

Print clearly. Answers will receive no marks if non-legible. Spelling counts.

Jonathan Braun, MD, PhD David Geffen School of Medicine at UCLA CCFA National Scientific Advisory Committee

The enteric microbiota: Implications for IBD. Eugene B. Chang, M.D. University of Chicago

There is no single IBD diet

New and Emerging Therapies in IBD. Sarah Streett MD, AGAF Clinical Associate Professor of Medicine Stanford University

HLA TYPING AND EXPRESSION: POTENTIAL MARKER FOR IDENTIFYING EARLY DYSPLASIA AND STRATIFYING THE RISK FOR IBD-CANCER

DIVISION OF GASTROENTEROLOGY

Featured Topic: Christmas Message

Personalized Medicine in IBD

Storytelling to Motivate Change in Food Safety

Environmental exposure: can we reduce risk?

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Mark Manary MD. International Symposium on Understanding Moderate Malnutrition in Children for Effective Interventions

The London Gastroenterology Partnership CROHN S DISEASE

Lecture 17: Human Genetics. I. Types of Genetic Disorders. A. Single gene disorders

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.

Diarrhea may be: Acute (short-term, usually lasting several days), which is usually related to bacterial or viral infections.

Page 1. Global trends in diet parallel IBD. Is there an anti-inflammatory diet for IBD? Patients want to know. Challenges in establishing causality

BUTYRATE PRODUCING BACTERIA AS PROBIOTIC TREATMENT IN IBD

Understanding Inflammatory Bowel Diseases (IBD):

A Case of Inflammatory Bowel Disease

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Tracking Genetic-Based Treatment Options for Inflammatory Bowel Disease

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

Genetic Susceptibility. Objectives. What Causes IBD? Inflammatory Bowel Disease

A. Incorrect! Cells contain the units of genetic they are not the unit of heredity.

Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute

Microbiome in You: Optimizing Gut Bacteria for Better IBD Management

Hot Topics In Nutrition & IBD January 6, Kate Vance, RD Wael N. Sayej, MD

Strategies for changing the course of Crohn s disease

My Child Has Inflammatory Bowel Disease : Why? What now? What s next?

Staying Healthy as an IBD patient

Gut Immunology. goes Africa October 2015

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease

CRC and Dysplasia in IBD: Objectives of Talk. Colorectal Cancer and Dysplasia in IBD: A Case-Based Approach. Page 1

GI update. Common conditions and concerns my patients frequently asked about

Research Update: Looking for the Answers

History of IBD in India

IBD :- a new era of diagnostics and therapy Dr Martyn Dibb Consultant Luminal Gastroenterologist Royal Liverpool University Hospital

The National Association of Crohn s and Colitis of Trinidad and Tobago CROHN S DISEASE AND ULCERATIVE COLITIS GENERAL PATIENT INFORMATION

Top 10 Things you need to know about IBD. Suresh Pola, MD Kaiser San Diego

Lower Gastrointestinal Tract KNH 406

INFLAMATION AND CANCER

Chapter 2. Overview of ankylosing spondylitis

Patients and Doctors: Bridging the Divide

Transcription:

Genetic and Environmental Risks for IBD CCFA April 26, 2014 Presented by: Name goes here April 30, 2014 TheoTheodore 1

Genetic and Environmental Risks for IBD Theodore M. Bayless, M.D. Director Emeritus Meyerhoff IBD Center.

Genetic and Environmental Risks for IBD

Estimated 1 Million Americans With IBD Ulcerative Colitis 50% Crohn s Disease 50% Approx 10% - 15% indeterminate colitis Cases per 100,000 persons Incidence (range) Prevalence (range) Ulcerative Colitis 2.2 15.6 38 246 Crohn s Disease 3.6 15.6 26 199

ULCERATIVE COLITIS AND CROHN S DISEASE

Inflammatory Bowel Disease IBD Ulcerative colitis Indeterminant Crohn s disease Distal Left-sided pancolitis Colitis Colitis Jejunoileitis Ileocolitis Ileitis Inflam Perf Stenotic

AGE AND SEX DISTRIBUTION OF IBD

IBD pathogenesis: 2014 Genetic Predisposition (innate immunity, barrier function, autoimmunity) IBD Mucosal Immune System (Immunoregulatory defect - disrupted homeostasis) Environmental Triggers (Lumenal bacteria, infection, barrier breakers)

Genes n DNA is composed of a sequence of four billion nucleotides. These sequences are found on 23 different chromosomes. Each person comes from 23 chromosomes from their mother (in the egg) and 23 chromosomes from their father (in the sperm). Males have an X and a Y chromosome Females have two X chromosomes

1985 1992: 554 Consecutive Crohn s Disease Patients at Johns Hopkins (TMB) 554 Crohn s Patients 120 (22%) IBD Family History (CD or UC) 96 (17%) CD Family History only 24 ( 4%) UC Family History only

IBD: Risk to Offspring n Lifetime Risk of IBD to a future child n One parent with IBD: 2 to 8% n One Jewish parent with IBD: ~ 10% n Multiple IBD relatives: > 10% n Both parents with IBD: 30-50% by age 21

Concordance of Phenotypes within CD Families Mother and Son, 13 Mother, ileitis Perforated at Age 28

Concordance of Phenotypes within CD Families Mother and Son, 26 Son, Perforated Ileum, 26

NOD2/CARD15: Mutations involved in 25% of Crohn s disease patients Younger age of onset 1,3 NOD2 Small bowel involvement 2-4 Fibrostenosing disease 1,5 20-40 fold increased risk for CD in NOD2 homozygotes Or compound heterozgotes

> 163 Gene Regions Identified for IBD Most risk for both Crohn and UC! 30% risk for other immune disease CD 30 IBD 110 UC 23 Immune Diseases 66 of 154 also IBD

IBD pathogenesis: 2013 Genetic Predisposition (innate immunity, barrier function, autoimmunity) IBD Mucosal Immune System (Immunoregulatory defect - disrupted homeostasis) Environmental Triggers (Lumenal bacteria, infection, barrier breakers)

Environmental Triggers of IBD Altered microflora Antibiotics Diet IBD Onset and Reactivation Altered mucosal barrier function and/or immunoregulatio Acute n infections NSAIDs Smoking Stress

Smoking: decreases risk for UC Increases risk for Crohn s disease Log of Relative Risk 0.4 0.3 0.2 0.1 0-0.1-0.2-0.3-0.4-0.5 ulcerative colitis Crohn's disease Risk of Disease in Smokers

Environmental Factors in Crohn s Disease Different in Ulcerative Colitis n Crohn s Disease n Ulcerative Colitis n Smoking Bowel Rest Antibiotics Appendectomy Acute Infection Chronic Infection Genes in CD: Innate Immunity/ Microbiome Interaction 0 0

ENVIRONMENTAL INFLUENCE: IBD PREVALENCE VARIES BY GEOGRAPHY: HIGH UC PREVALENCE IN SOUTH ASIANS MIGRATED TO UNITED KINGDOM UK prevalence 0.18% GEOGRAPHICAL PREVALENCE OF IBD N. India prevalence 0.04% Singapore Prevalence 0.02% Yang, Inflamm Bowel Dis, 2001 Lee, J Gastroenterol Hepatol, 2000

What about Westernization and higher latitudes that leads to greater IBD? n Western Diet? Higher intake of animal protein associated 3-fold risk 1 Milk derived fats associated with colitis in an animal model 2 n Modern bacterial selection? Antibiotic use associated with IBD? Cold Chain Hypothesis - (possible triggers like Listeria and Yersinia)? n Hygiene Effect? Crohn s protected by Vietnam service and POW status 3 Helminths can protect in animal models, can decrease TH1, TH2 and TH17 response and are being evaluated in clinical trials 4 n Low Vitamin D Lower UV radiation exposure in France and in US associated with Crohn s and with severity (Limketkai et al)

Messages n Individual with positive family history of Crohn s Disease or of Ulcerative Colitis is at increased risk for IBD n Risk to sibling is 5%; risk to offspring is 2-8% n Smoking increases the risk of developing Crohn s Disease ( Please, don t smoke )

Messages n Average age of diagnosis of IBD is 27. Onset in childhood or teenage in 20% n 90% of pre-pubscent CD patients have change in growth before dx made. n At least 10% of IBD have co-existent Irritable Bowel Syndrome (IBS) n A family history of Irritable Bowel Syndrome (IBS) is very common and is NOT a risk factor for IBD.

Genetic and Environmental Risks for IBD